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1. Introduction
  Hawthorn, a common name of all plant species in the 
genus Crataegus, is a thorny shrub or small tree[1]. Hawthorn 
is a member of the Rosaceae family and is recognized to 
have approximately 280 species primarily from northern 
temperate zones in East Asia, Europe, and eastern North 
America[2, 3]. Crataegus sinaica (C. sinaica)  grows wildly in 
the mountains area in Saint Catherine Protectorate, South 
Sinai, Egypt, and known as Za’rur or Za’rur al-awdiyah[4]. 
Flavonoids and procyanidins are considered as the most 
important constituents and primarily responsible for the 
pharmacological activity of hawthorn[5]. The fruits contain 
relatively low levels of flavonoids and consist primarily of 
oligomeric and polymeric procyanidins[6]. Data regarding 
the young stems and seeds are lacking. Among cardioactive 
medicinal plants that do not contain typical cardiac 
glycosides, hawthorn (Crataegus) has taken a special 
position since centuries[7]. Crataegus species are famous in 
folk medicine and are widely used in phytotherapy due to 
their improvement of the heart function in declining cardiac 
performance equivalent to stages I and II of the NYHA 
classification[8-10]. It was deemed important to evaluate the 
phytoconstituents and bioactivities of C. sinaica growing 
in Egypt. The antiviral and antioxidant activity of some 
fractions and of a series of flavonoids and proanthocyanidins 
obtained from C. sinaica was valuated[11]. The O-glycosidic 
flavonoids and oligomeric proanthocyanidins exhibited 
significant inhibitory activity against herpes simplex 
virus type 1 (HSV-1), which was shown to be due to an 
extracellular mechanism for procyanidin C1[12]. However, 
studies evaluating cardiac activity and hepatoprotection of 
C. sinaica have not done yet.
2. Materials and methods
2.1. General experiment
Objective: To evaluate the cardiac activity and hepatoprotection of Crataegus sinaica 
(C. sinaica). Methods: All the isolated compounds were isolated by open-column liquid 
chromatography (CC) using sephadex LH-20 as stationary phase. Elution of the column was 
performed with EtOH or MeOH. The phytochemical investigation of the young stem of C. sinaica 
for the first time together with the leaves and flowers lead to the isolation and identification 
of quercetin,  hyperoside, vitexin-2''-O-rhamnoside, epicatechin, procyanidin B2 and 
procyanidins C1. Results: Rats treated with the low and high dose of C. sinaica leaves with 
flowers extract showed 15% and 17% reduction in the heart rate, and reduction in the ST-
segment by 107% and 57%; respectively. The T-amplitude was decreased by 59% of the high 
dose extract. On the other hand, the young stems and leaves with flowers extracts of C. sinaica on 
primary culture of rat hepatocytes monolayer indicated a hepatoprotection for the total extract, ethyl 
acetate, butanol, and chloroform fractions at 100 毺g/mL, 75 毺g/mL, 50 毺g/mL, and 25毺g/mL; 
respectively. Conclusions: The results of these chemical and biological studies suggest the use 
of C. sinaica growing in Egypt as a preventive drug against cardiovascular and hepatic diseases. 
The chemical studies suggest the use of woody young stems as a newly investigated bioactive 
organ. The extraction of unsaturated fatty acids from the seeds of the plant would serve as a good 
health and nutritive product. 
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 TLC was carried out on precoated 0.2 mm layer silica gel 
F254 plates (Merck) developed with ethyl acetate - formic 
acid - acetic acid–water (30:1.2:0.8:8 v/v).  Spots were 
detected using naturstoff (NA) reagent (2-aminoethyl 
diphenylborate) 1% w/v in absolute methanol for 
flavonoids[13], reagent (ii) (vanillin 1% in MeOH and 5% 
H2SO4 in EtOH) for proanthocyanidins analysis[12], UV 
at 254 and 366 nm for UV detection. UV spectra were 
measured as diluted samples in MeOH on a Uvikon 931 
double beam UV-VIS spectrophotometer in the region of 
200-500 nm. FAB-MS spectral analyses in negative or 
positive mode were performed on a VG 70-SEQ hybrid 
mass spectrometer. EIMS were recorded on the same 
instrument by means of a direct insertion probe at ionization 
energy of 70 ev. 1H-and 13C-NMR spectra were recorded in 
CD3OD, or DMSO-d8 on a Bruker DRX-400 instrument. 
The chemical shifts were reported in values (ppm) with TMS 
as the internal standard.
2.2. High performance liquid chromatography analysis
  High performance liquid chromatography(HPLC) 
analysis was carried out using Agilent 1 200 equipment 
with quaternary pump, auto sampler injector.  The 
chromatograms were detected with a DAD (80 Hz) for 
full spectral acquisition. The automated Quaternary LC 
system was operated and data was managed using Hewlett-
Packard model computer. Zobrax Eclipse XDB-C18 
Column (Analytical 4.6 伊150 mm; 5 microns) was used at 
temperature 25 曟.
2.3. Plant materials
  C. sinaica were obtained from Wadi Gebal in Saint 
Catherine Protectorate (South Sinai, Egypt) in November 
2005. Voucher specimens were kindly identified by Prof. 
Dr. K. H. El-Batanouny, Botany Department, Faculty of 
Science, Cairo University, Egypt. It was air-dried, then 
segregated into leaves with flowers, young stems, and fruits; 
from which seeds were further separated. 
2.4. Authentic reference compounds
 Quercetin were previously isolated and purified from 
the leaves of C. sinaica[11]. Vitexin-2''-O-rhamnoside & 
hyperoside were purchased from ROTH.  Epicatechin was 
purchased from Sigma Chemical Co. (St. Louis, MO).  B2 
and C1 were previously isolated and purified from the leaves 
of C. sinaica[12]. 
2.5. Extraction and isolation
  The air-dried and powdered leaves with flowers and 
young stems (1 500 g), and fresh fruits (2 000 gm) were 
extracted exhaustively with 70% and 80% aqueous acetone; 
respectively at room temperature. The combined filtrates were 
concentrated in vacuo at 40 曟 then subjected to lyophilization. 
Then extracted successively with CHCl3 (300 mL 伊 3), EtOAc 
(500 mL 伊 5), and BuOH (150 mL 伊 3); respectively. Each 
fraction was completely dried in vacuo at 40 曟and the final 
dry weight was noted. 
2.6.Sample preparation for HPLC
  Two g of dried powder were extracted 3 times with 200 mL 
70% acetone. The extract was reduced to about 10 mL 
in vacuo and then diluted with 20 mL of distilled water 
and defatted with petroleum ether. The aqueous layer was 
evaporated to dryness, then dissolved in methanol and 
transferred to a 25 mL measuring flask and continued to the 
mark with methanol (solution A). 5 mL of solution A were 
filtered through a 25 mm filter, pp 0.45 Nylon and diluted 
to 10 mL with methanol. A 20 毺L of this solution was 
injected. 
2.7. Solvent system
  Isocratic elution of A: Water/Formic acid (0.05%) 
(86%) and B: Acetonitrile (14%). Standard authentics 
concentration: 1 mg/mL (0.8 mL/min flow rate). 
2.8. Biological activities analysis 
  In vivo bioassay using cardiac activity was performed 
according to the method of Vish Nevskeya[14]. For this 
purpose 36 rats weighing 250-300 g were used (from 
the animal house colony of the NRC) and Epinephrine 
(Epinephrine®) was purchase from Misr for pharmaceutical 
products, Egypt. It has been established that within 5 
minutes of intramuscular injection of 0.8 mL epinephrine 
in white rats myocardial ischemia appeared. ECG changes 
appeared in the form of depressed ST-segment, heart rate 
changes and diminution or inversion of the T-amplitude.
  Rats were divided into 5 groups as follow: The 1st group 
served as control and received distilled water, the 2nd and 
3rd group received low dose level (10 mg/kg/day) and high 
dose level (100 mg/kg/day) of C. sinaica leaves with flowers 
extract; respectively, the 4th and 5th group received low 
dose level (10 mg/kg/day) and high dose level (100 mg/kg/
day) of the leaves with flowers extract standard (Crataegi 
Foui Cum Flore Extract; Siccum, Certa, from Belgium); 
respectively. The ECG changes were measured using ECG 
in standard lead II using power lab ECG module.
2.9. Hepatoprotection and cytotoxicity using MTT 
colorimetric assay
 Primary culture of rat hepatocytes was prepared according 
to method[15], modified by Kiso[16], using Westar male rats 
(250-300 g), obtained from the animal house of the NRC. 
Culture medium composed of RPMI-1640 medium(100 mL), 
supplemented with 10% inactivated (56 曟 for 30 min) fetal 
calf serum (FBS), penicillin-streptomycin (PS) (0.01 g/mL), 
insulin (0.7 g/mL) and dexamethasone (4 g/mL). All items 
were purchased from Sigma-aldrich Company. Inocula of 
4伊106 cells/mL were seeded into sterile plastic 96-well 
plates and incubated in CO2-Incubator at 37 曟, under 5% 
CO2 in air for 22-24 hrs. All buffers were freshly prepared 
and sterilized at 121曟 for 30 min. before use. Four extract 
and fractions (total acetonic extract and EtOAc,  BuOH and 
CHCl3 fractions) from both the leaves with flowers and young 
stems extracts of C. sinaica were tested for their potential 
cytotoxic and hepatoprotective activity. 
  Evaluation of hepatoprotective activity undergo by 
preparing different concentrations from each of the extracts 
of C. sinaica, starting from 25 毺g/mL and increasing 
concentrations in ascending order by dissolving in DMSO 
(1% maximum concentration).  For each concentration, 
three replicates were carried out, in addition to controls 
which were: cell control (i.e., cells only), 50% of cell 
control, negative control: 20 mM paracetamol (i.e., cells + 
paracetamol), positive control: 50 毺g/mL Sylimarin (i.e., 
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cells + sylimarin + paracetamol).
  In order to determine LC50, different concentrations 
were prepared for each of the extracts. The range of 
concentrations used started from 100 毺g/mL followed 
by increasing concentrations in ascending order up to the 
concentration 1 000 毺g/mL to determine the concentration 
that induce death for half the number of cells. C. sinaica 
extracts were dissolved in dimethylsulphoxide (DMSO) (1% 
maximum concentration). For each concentration, three 
replicates were carried out, in addition to controls which 
were: Cell control (i.e., cells only), 50% of cell control
  Evaluation of the effect of the different extracts on cultured 
hepatocytes was obtained by calculating the absorption of 
the cell viability with respect to control cells (cells only 
without addition of C. sinaica extracts). Each experiment 
was carried out twice to confirm validity of results. A graph 
was plotted with x-axis showing different concentrations 




3.1.1. Cardiovascular activity 
  All groups showed no significant effect for the ECG 
changes after one week administration of the drug. In the 
positive control group heart rate was reduced by 27% and 
the ST-segment was reduced by 247%.
  Rats treated by the low and high dose of C. sinaica leaves 
with flowers extract showed 15% and 17% reduction in 
the heart rate, and reduction in the ST-segment by 107% 
and 57% respectively. The T-amplitude was decreased by 
59% of the high dose extract. On the other hand, the rats 
treated by the low and high dose of the leaves with flowers 
extract standard (Crataegi Foui Cum Flore Extract) showed 
27% and 22% reduction in the heart rate and reduction 
in the ST-segment by 111% and 42%; respectively. The 
T-amplitude was decreased by 41% of the high dose 
standard (Table 1, Figure 1 & 2).
Figure 1. Effects on rats’ heart within 5 min after epinephrine 
injection.
  Both the standard drug and the tested extracts showed a 
protective effect on the heart especially in the high dose 
level. These results prove the efficacy of Crataegus growing 
in Egypt and possibility of using it therapeutically in 
cardiovascular diseases.
3.1.2. Hepatoprotection and cytotoxicity
  Data were subjected to analysis of variance and treatment 
means were compared by an approximate Student’s t-test 
(P<0.05). All treatments in experiments described consisted 
of three replicates.
  The results of leaves with flowers, as well as, young 
stems extracts of C. sinaica indicated that they exhibited 
hepatoprotection for total extract, ethyl acetate, butanol, and 
chloroform fractions at 100 毺g/mL, 75 毺g/mL, 50 毺g/mL, 
and 25 毺g/mL; respectively (Figure 3 & 4, Table 2 & 3). 
  The viability assay was applied with a broad range of 
concentrations of the studied extracts (from 100-1000 mg/mL) 
on monolayer of rat hepatocytes. It revealed that with 
the given extracts, increasing absorbance values were 
observed with increasing concentrations from 100毺g/mL to 
1 000 毺g/mL in monolayer culture of primary rat 
hepatocytes except in the CHCl3, however no cytotoxicity 
was observed microscopically in the cellular systems, as 
shown in Table 4, 5 and Figure 5, 6.  
Figure 2. Effects on ST-segment within 5 min after epinephrine 
injection.
 
Figure 3. Viability of rat hepatocyte after treatment with different 
concentrations of leaves extracts followed by treatment with 
paracetamol using MTT colorimetric assay.
*Each point represents the Mean±SD (n=3).
Figure 4. Viability of rat hepatocytes after treatment with different 
concentrations of branch extracts followed by treatment with 
paracetamol using MTT colourimetric assay.
*Each point represents the Mean±SD (n=3).
Alaa Tawfeek Refaat et al./Asian Pacific Journal of Tropical Medicine (2010)257-261260
Figure 5. Viability of rat hepatocytes after treatment with different 
concentrations of the leaves extracts using MTT colorimetric assay.
*Each point represents the Mean±SD (n=3).
 
*
Figure 6: Viability of rat hepatocytes after treatment with different 
concentrations of the young stems extracts using MTT colourimetric 
assay.
*Each point represents the Mean±SD (n=3).
Table 1
Effects on rats within 5 min after epinephrine injection.        
Item Control Low dose ext. Low dose st. High dose ext. High dose st.
Heart rate
Value 
Before injection 284.28±28.07 272.24±32.91 312.34±25.42 271.62±17.13 310.17±17.99
After injection 217.36±19.60 229.87±30.08  228.69±4.95 *  245.07±9.66 * 238.05±25.73
Percentage change -27% -15% -27% -17% -22%
ST-segment
Value
Before injection -0.016±0.016 -0.020±0.018 -0.021±0.017   0.000 47±0.010 00 -0.016±0.010
After injection -0.066±0.037 -0.027±0.020   -0.035±42.060 -0.009 63±0.009 70 -0.024±0.012
Percentage change -247% -107% -111% -57% -42%
* P< 0.05: significantly different from its basal result. (Paired t-test two sided).
 
Table 2
Hepatoprotection of different concentrations of C. sinaica leaf fractions.     
Sample concentration 毺g/mL
Absorbance percentage (Mean ± SD)
Total acetonic extract EtOAc fraction BuOH fraction CHCl3 fraction
25 44.8±1.2 61.3±1.9   47.1±0.8 96.9±2.7
50 67.6±3.5 87.1±4.8   76.9±4.3 88.9±2.1
75 58.2±4.5 95.1±7.1   92.0±5.8 74.7±3.0
100 91.1±5.1 95.1±5.8 104.4±5.4 36.8±1.3
100% cell control  100±4.0*
50% cell control 50.6±1.1*
Paracetamol 59.1±0.7*
Silymarin    96±7.0*
*Absorbance percentage relative to control (= 100% cells; 50% cells; Silymarin, 50 毺g/mL and paracetamol, 20 mM. 
Table 3




Total acetonic extract EtOAc fraction BuOH fraction CHCl3   fraction
25 61.7±0.2    76.6±0.7   61.2±0.9 80.3±2.9
50 72.3±1.4    92.6±2.2   75.0±0.9 79.8±2.3
75 80.3±1.5    96.3±1.7   97.3±2.4 78.7±2.9
100 93.6±1.2  100.5±5.4 101.6±2.1 59.6±1.1
100% cell control  100 ±1.1*
50% cell control 53.2 ±2.1*
Paracetamol  58.0±1.8*
Silymarin  99.5±1.0*
  *Absorbance percentage relative to control [(= 100% cells, 50% cells, Silymarin (50 毺g/mL) and paracetamol (20 mM)]. 
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 4. Discussion
  The need for drugs originating from plant materials, and 
directed for preventing serious diseases as cardiovascular 
and hepatic diseases is a national need. In this study, the 
identification of C. sinaica compounds was elucidated 
by means of TLC, FAB-MS, NMR spectroscopy and co-
chromatography with HPLC. The cardiovascular and 
hepatoprotective activities of different fractions obtained 
from C. sinaica leaves with flower and the young stems 
extracts were investigated. 
  The main active constituents such as hyperoside, vitexine-
2”-O-rhamnoside, epicatechin, procyanidin B2 and 
procyanidin C1 were isolated and identified from the young 
stems and confirmed by comparison with previously reported 
data[11,17]. The presence of those main active constituents 
explains the biological results discussing the similarity 
of bioactivities of both C. sinaica and other species used 
abroad in phytopharmaceuticals. These new findings allow 
the use of young stems beside the leaves of C. sinaica 
biologically.
  The increase of absorbance values in some samples was 
not false negative result for cytotoxicity, as microscopic 
examination confirmed the viability of the cultured 
hepatocytes.
  The revealed data showed no cytotoxicity exerted by the 
leaves or young stems of C. sinaica in the given range, but 
leaves had greater safety margin. Also, the chloroformic 
extract in both parts had a decreasing safety margin with 
increased concentration. For the hepatoprotection, almost 
complete hepatoprotection occurred for all fractions of 
leaves and young stems taking in consideration that the 
chloroformic extracts always showed prominent at low doses 
and protection decreased with increased concentration. 
These new findings may have great impact for future use of 
C. sinaica for the first time in hepatic disorders.
  In conclusion, the results of these chemical and biological 
studies suggest the use of C. sinaica growing in Egypt as a 
preventive drug against cardiovascular and hepatic diseases. 
The chemical studies suggest the use of woody young stems 
as a newly investigated bioactive organ. The extraction of 
unsaturated fatty acids from the seeds of the plant would 
serve as a good health and nutritive product. 
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Table 4
Hepatotoxicity of different concentrations of C. sinaica leaves fractions.    
Sample concentration 
(毺g/mL)
Absorbance percentage (Mean ± SD)
Total acetonic extract EtOAc fraction BuOH fraction CHCl3 fraction
100 100.0±3.8  126.8±2.1   177.4±15.3 106.9±8.2
250 167.2±5.0 154.1 ±7.9 180.3±8.6 103.8±7.3
500 181.3±8.6  157.3±8.3 187.5±9.6    102±6.2
750 216.7±8.6 163.3 ±7.1   202.6±10.8   90.8±4.4
1 000   227.9±12.3    203.3±18.5   220.7±10.6   75.7±2.0
100% cell control 100.0±6.8*
50% cell control   54.4±5.6*
*Absorbance percentage relative to control (= 100% and 50%)
 
Table 5
Hepatotoxicity of different concentrations of C. sinaica branch fractions.   
Sample concentration 
(µg/mL)
Absorbance percentage (Mean ± SD)
Total acetonic extract EtOAc fraction BuOH fraction CHCl3 fraction
100   98.0±5.8   84.0±1.4   90.8±4.5 97.4±6.3
250 105.4±6.2   96.4±7.2 101.4±3.6 94.8±4.6
500 117.4±3.6 126.8±8.8 131.2±3.4 92.8±6.3
750 115.1±7.2 257.0±4.6 129.4±4.4 89.0±3.1
1 000 116.7±7.9 155.3±9.0 128.0±2.9 69.5±6.0
100% cell control 100.0±5.8*
50% cell control   52.1±1.2*
*Absorbance percentage relative to control (= 100% and 50%).
